Lilly Wachowski accused J.K. Rowling of "funding anti-trans legislation all over the world," calling her actions "trans genocide." Wachowski also referred to Rowling and Elon Musk as "literal Nazis." ...
There are a little more than three months until the premiere of HBO Max’s Harry Potter series, which means there’s still time to stop people who want to engage with its nostalgic, drab Muggleslop ...
Eli Lilly & Co. has been laying the groundwork for a broader move into women’s health, assembling experts and hunting for new medicines across conditions including bone health and endometriosis, ...
Eli Lilly Stock Has Become a Trillion-Dollar Giant. Is It Too Late to Buy? Eli Lilly just crossed the trillion-dollar threshold on the back of a GLP-1 empire growing at nearly 50% annually, but a ...
Eli Lilly remains on a shopping spree, agreeing to pay up to $2.875 billion in cash for biotechnology company Merida Biosciences in a deal that bolsters the drugmaker’s immunology portfolio. Eli Lilly ...
Eli ⁠Lilly said on Monday it would acquire privately held Merida Biosciences for up to $2.88 billion in cash, strengthening its immunology portfolio with an experimental treatment for thyroid-related ...
Deal helps Lilly expand immunology pipeline, diversify beyond obesity drugs Merida's lead drug candidate targets Graves' disease and thyroid eye disease Transaction valued at up to $2.88 billion in ...
Eli Lilly has launched its Foundayo weight-loss pill in the U.K., making the country the first in Europe to offer the oral treatment. The drug is available from Monday of this week, initially through ...
Eli Lilly (NYSE:LLY | LLY Price Prediction) just posted one of the most impressive quarters in Big Pharma history. Revenue jumped 47.67% to $22.974 billion, Mounjaro alone did $9.943 billion, and ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Eli Lilly said Wednesday it is suing six companies selling versions of its experimental weight-loss drug retatrutide, calling it the beginning of a concerted effort to crack down on a vast illicit ...
Eli Lilly is suing six entities that it alleges are selling black market versions of its experimental weight-loss drug retatrutide. Lilly’s lawsuits target U.S. entities selling illegal retatrutide ...